SkinVision
Amsterdam
About SkinVision
SkinVision is an awareness and tracking solution that supports individuals with the early recognition of melanoma, squamous cell carcinoma, basal cell carcinoma and precancerous actinic keratosis. SkinVision is the first certified skin cancer application globally based on extensive clinical trials in partnership with the university clinic of Ludwig Maximilian University (LMU) in Munich in 2013, published in the JEADV in 2014. The company has built up a customer portfolio of 1,200,000 users globally and a database of 3,5 million pictures of suspicious skin conditions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.5M
- Last round: Series Unknown (Feb 2020)
- Website: skinvision.com
- Phone: 0031 20 754 6571
Industries & Categories
Health Care, Information Technology, Medical Device, mHealth
Social Profiles
Canonical: https://fsome.com/organization/skinvision-94724 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.